|
Sept. 17, 2025
| This week’s commercialization news and insights for biopharma leaders
Susan Monarez told Senators at a hearing Wednesday that Robert F. Kennedy Jr. pushed her out for refusing to rubber-stamp changes.
|
UPDATED
HHS nominated five new members to ACIP ahead of a meeting Thursday and Friday that could prove an inflection point in HHS Secretary Kennedy’s efforts to overhaul U.S. vaccine policy.
|
The British drugmaker’s commitment comes as some of its pharma peers question their U.K. presence amid a widening row there over pricing polices.
|
Artificial intelligence promises a major revolution for biopharma, from drug discovery to clinical trials. Explore how Bristol Myers Squibb uses AI to validate drugs before they’re even in the lab in
|
Early academic research suggests various ways weight loss drugs could have an impact in cancer care.
|
News roundup
Lilly claimed success in a head-to-head trial of oral GLP-1 drugs. Elsewhere, Novo planned a new weight loss trial and an AI-focused startup raised its second “megaround.”
|
From Our Library
Webinar - on demand
Custom content for Endava
|
Infographic
Custom content for Woven Health Collective
|
View all resources
What We're Reading
Reuters
|
The Guardian
|
Reuters
| | 
